retatrutide updates Demand for Unapproved Weight-Loss Drug Surges on Social Media ADA 2026 Obesity Drug Updates:

It took Knudsen three years to determine why this happened

How does my surgery prep interact with a GLP-1 dosing schedule

Prescription copy, original pharmacy packaging, and a GP letter if you have one

Retatrutide is a new treatment for those who are overweight or living with obesity The medication has not yet received approval or become available It works by targeting three different receptors at the same time Clinical trials to date suggest potential weight loss of up to 24% Side effects seem to be similar to those seen with other GLP-1 medications About Retatrutide Retatrutide is a new treatment for those who are overweight or living with obesity The medication has not yet received approval or become available It works by targeting three different receptors at the same time Clinical trials to date suggest potential weight loss of up to 24% Side effects seem to be similar to those seen with other GLP-1 medications Retatrutide: new weight loss medication in development Retatrutide is a new medication that is currently attracting considerable attention as a potential treatment for overweight and obesity

BONUS FACTS ABOUT GLP-1 MEDS In addition to managing patients weight loss and type-2 diabetes, GLP-1 medications may have the potential to reduce addictive tendencies

Further, the CVOTs in general also suggested a potential benefit of GLP-1 RAs on HF, positioning GLP-1 RAs as another advanced option alongside SGLT2 inhibitors in the otherwise sparse treatment armamentarium for especially HFpEF